BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23625597)

  • 1. Expression of AEG-1 and p53 and their clinicopathological significance in malignant lesions of renal cell carcinomas: a microarray study.
    Erdem H; Oktay M; Yildirim U; Uzunlar AK; Kayikci MA
    Pol J Pathol; 2013 Apr; 64(1):28-32. PubMed ID: 23625597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue.
    Zigeuner R; Ratschek M; Rehak P; Schips L; Langner C
    Urology; 2004 Apr; 63(4):651-5. PubMed ID: 15072872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic and diagnostic implications of epithelial cell adhesion/activating molecule (EpCAM) expression in renal tumours: a retrospective clinicopathological study of 948 cases using tissue microarrays.
    Zimpfer A; Maruschke M; Rehn S; Kundt G; Litzenberger A; Dammert F; Zettl H; Stephan C; Hakenberg OW; Erbersdobler A
    BJU Int; 2014 Aug; 114(2):296-302. PubMed ID: 24215118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of clinicopathological parameters with FoxM1 expression in renal cell carcinoma.
    Kocarslan S; Guldur ME; Ekinci T; Ciftci H; Ozardali HI
    J Cancer Res Ther; 2014; 10(4):1076-81. PubMed ID: 25579557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoplasmic expression of Twist1, an EMT-related transcription factor, is associated with higher grades renal cell carcinomas and worse progression-free survival in clear cell renal cell carcinoma.
    Rasti A; Madjd Z; Abolhasani M; Mehrazma M; Janani L; Saeednejad Zanjani L; Asgari M
    Clin Exp Med; 2018 May; 18(2):177-190. PubMed ID: 29204790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of AEG-1 in renal cell carcinoma and its correlation with tumor nuclear grade and progression.
    Chen W; Ke Z; Shi H; Yang S; Wang L
    Neoplasma; 2010; 57(6):522-9. PubMed ID: 20845990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of the enzyme that esterifies retinol, lecithin:retinol acyltransferase, in subtypes of human renal cancer and normal kidney.
    Zhan HC; Gudas LJ; Bok D; Rando R; Nanus DM; Tickoo SK
    Clin Cancer Res; 2003 Oct; 9(13):4897-905. PubMed ID: 14581364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical expression of p53 and bcl-2 proteins is not associated with sarcomatoid change in renal cell carcinoma.
    Kanamaru H; Li B; Miwa Y; Akino H; Okada K
    Urol Res; 1999 Jun; 27(3):169-73. PubMed ID: 10422817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clear cell-papillary renal cell carcinoma of the kidney not associated with end-stage renal disease: clinicopathologic correlation with expanded immunophenotypic and molecular characterization of a large cohort with emphasis on relationship with renal angiomyoadenomatous tumor.
    Aron M; Chang E; Herrera L; Hes O; Hirsch MS; Comperat E; Camparo P; Rao P; Picken M; Michal M; Montironi R; Tamboli P; Monzon F; Amin MB
    Am J Surg Pathol; 2015 Jul; 39(7):873-88. PubMed ID: 25970682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenase-2 and p53 expression as prognostic indicators in conventional renal cell carcinoma.
    Cho DS; Joo HJ; Oh DK; Kang JH; Kim YS; Lee KB; Kim SJ
    Yonsei Med J; 2005 Feb; 46(1):133-40. PubMed ID: 15744816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of CD95 and COX-2 in renal cell carcinomas with survival and other prognostic parameters: A tissue microarray study.
    Erdem H; Aydin HR; Bahadir A; Gündogdu B; Balta H; Sener E; Kayikci MA; Albayrak A; Erdogan F
    J Pak Med Assoc; 2015 Jun; 65(6):597-601. PubMed ID: 26060153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human telomerase reverse transcriptase protein expression predicts tumour aggressiveness and survival in patients with clear cell renal cell carcinoma.
    Saeednejad Zanjani L; Madjd Z; Abolhasani M; Rasti A; Shariftabrizi A; Mehrazma M; Fodstad Ø; Asgari M
    Pathology; 2019 Jan; 51(1):21-31. PubMed ID: 30466948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of P-glycoprotein, p53, and survivin expression in renal cell carcinoma.
    Baytekin F; Tuna B; Mungan U; Aslan G; Yorukoglu K
    Urol Oncol; 2011; 29(5):502-7. PubMed ID: 19945306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of extensive necrosis in renal cell carcinoma.
    Collins J; Epstein JI
    Hum Pathol; 2017 Aug; 66():108-114. PubMed ID: 28669641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct immunophenotypes and prognostic factors in renal cell carcinoma with sarcomatoid differentiation: a systematic study of 19 immunohistochemical markers in 42 cases.
    Yu W; Wang Y; Jiang Y; Zhang W; Li Y
    BMC Cancer; 2017 Apr; 17(1):293. PubMed ID: 28449664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of p53 and bcl-2 in primary locally confined renal cell carcinomas: no evidence for prognostic significance.
    Hofmockel G; Wittmann A; Dammrich J; Bassukas ID
    Anticancer Res; 1996; 16(6B):3807-11. PubMed ID: 9042262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of bcl-2, p53 oncoprotein, and proliferating cell nuclear antigen in renal cell carcinoma.
    Sejima T; Miyagawa I
    Eur Urol; 1999; 35(3):242-8. PubMed ID: 10072628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the EphA1 protein is associated with Fuhrman nuclear grade in clear cell renal cell carcinomas.
    Wang X; Liu Y; Cao G; Zhang X; Xu H; Xu H; Wang J
    Int J Clin Exp Pathol; 2015; 8(6):6821-7. PubMed ID: 26261568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinicopathological features and prognosis of renal cell carcinoma with sarcomatoid differentiation].
    Jiang Y; Su G; Yu W; Li J; Lu Q; Li Y; Zhang W
    Zhonghua Zhong Liu Za Zhi; 2015 Nov; 37(11):823-6. PubMed ID: 26887511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 expression in correlation to clinical outcome in patients with renal cell carcinoma.
    Ljungberg B; Bozoky B; Kovacs G; Stattin P; Farrelly E; Nylander K; Landberg G
    Scand J Urol Nephrol; 2001 Feb; 35(1):15-20. PubMed ID: 11291681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.